Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion type Assertion NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_head.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion description "[Frequency of ETS gene aberrations in both groups was correlated with cancer progression including prostate-specific antigen progression, Gleason progression, and progression-free survival by logistic analysis, pairwise differences, and chunk likelihood ratio tests for the genotype groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_provenance.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion evidence source_evidence_literature NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_provenance.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion SIO_000772 25175425 NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_provenance.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion wasDerivedFrom befree-2016 NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_provenance.
- NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_assertion wasGeneratedBy ECO_0000203 NP1215640.RALWSGNddujuxom-dC5hi2uZ_bDkKz183tS4o_QFOyoqU130_provenance.